Selected article for: "acute sars cov respiratory syndrome coronavirus and lymphoma cell"
Author: Gesiotto, Quinto; Cheema, Asima; Avaiya, Kishan; Shah, Bijal; Greene, John
Title: COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia
  • Cord-id: 4lzd8yln
  • Document date: 2021_5_26
    • ID: 4lzd8yln
    Snippet: The world is experiencing the COVID-19 outbreak and there are no evidence-based treatment strategies available for immunocompromised patients. COVID-19 is a novel beta coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with cancer are more susceptible to infection than individuals without cancer due to their impaired humoral and cellular immune function caused by the malignancy itself and chemotherapy. We present three cases of cancer patients with hypoga
    Document: The world is experiencing the COVID-19 outbreak and there are no evidence-based treatment strategies available for immunocompromised patients. COVID-19 is a novel beta coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with cancer are more susceptible to infection than individuals without cancer due to their impaired humoral and cellular immune function caused by the malignancy itself and chemotherapy. We present three cases of cancer patients with hypogammaglobulinemia with varying clinical outcomes associated with infection. These include one mantle cell lymphoma patient with recurrent respiratory infection requiring intravenous immunoglobulin (IVIG) support and two multiple myeloma patients with continued viral shedding.

    Search related documents:
    Co phrase search for related documents
    • activity relationship and long incubation period: 1
    • activity relationship and lung cancer: 1
    • additional risk and long follow: 1
    • additional risk and lung cancer: 1, 2, 3
    • additional risk and lymph node: 1
    • long follow and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • long follow and lymph node: 1, 2, 3, 4, 5, 6, 7, 8
    • lung cancer and lymph mediastinal hilar: 1, 2, 3, 4
    • lung cancer and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lung cancer and lymphocytic leukemia: 1, 2
    • lung cancer and lymphoma multiple myeloma: 1, 2
    • lung nodule and lymph node: 1, 2, 3, 4, 5